Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia

Saved in:
Bibliographic Details
Published in:Blood advances 2023-08, Vol.7 (16), p.4319-4322
Main Authors: Rankine-Mullings, Angela, Keenan, Russell, Chakravorty, Subarna, Inusa, Baba, Telfer, Paul, Velangi, Mark, Ware, Russell E., Moss, Jon J., Lloyd, Adam L., Edwards, Sarah, Mulla, Hussain
Format: Article
Language:English
Subjects:
Research Letter
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c480t-5c87ab238b69a7868555f234af7ff426c7374116e811a6fbcdbd6dadfa539bd43
cites cdi_FETCH-LOGICAL-c480t-5c87ab238b69a7868555f234af7ff426c7374116e811a6fbcdbd6dadfa539bd43
container_end_page 4322
container_issue 16
container_start_page 4319
container_title Blood advances
container_volume 7
creator Rankine-Mullings, Angela
Keenan, Russell
Chakravorty, Subarna
Inusa, Baba
Telfer, Paul
Velangi, Mark
Ware, Russell E.
Moss, Jon J.
Lloyd, Adam L.
Edwards, Sarah
Mulla, Hussain
description
doi_str_mv 10.1182/bloodadvances.2023010099
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10424132</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2473952923002513</els_id><sourcerecordid>2813565222</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-5c87ab238b69a7868555f234af7ff426c7374116e811a6fbcdbd6dadfa539bd43</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EolXpX6h85LAp_kji5ISgagtSJS5wtib2mJgm8dZOtuTf49W2Cz1xmpHmnWc-XkIoZ5ecN-JDN4Rgwe5gMpguBROSccba9hU5FaWSRVtJ9fqYi_aEnKf0izHGVS2rVrwlJ1JxxWvGTsly7Zw3YNYNTeBwzhEmS7c9xBFMuPcTzt4kGhwFOuHjhkYEuxZzKJaEGzr4h8Vb2q82ht_rkovUT9T0frARJ_ro554mb-4HpAaHIcNx9PCOvHEwJDx_imfkx83196svxd23269Xn-4KUzZsLirTKOiEbLq6BdXUTVVVTsgSnHKuFLVRUpWc19hwDrXrjO1snV_joJJtZ0t5Rj4euNulG9EanOYIg95GP0JcdQCvX1Ym3-ufYac5K0XJpciE90-EGB4WTLMefdpfkg8JS9Ki4bKqKyH20uYgNTGkFNEd53Cm987pF87pv87l1ot_9zw2PvuUBZ8PAszf2nmMOhmPGWN9RDNrG_z_p_wBW2ux8w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2813565222</pqid></control><display><type>article</type><title>Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia</title><source>PubMed Central (Open access)</source><source>ScienceDirect (Online service)</source><creator>Rankine-Mullings, Angela ; Keenan, Russell ; Chakravorty, Subarna ; Inusa, Baba ; Telfer, Paul ; Velangi, Mark ; Ware, Russell E. ; Moss, Jon J. ; Lloyd, Adam L. ; Edwards, Sarah ; Mulla, Hussain</creator><creatorcontrib>Rankine-Mullings, Angela ; Keenan, Russell ; Chakravorty, Subarna ; Inusa, Baba ; Telfer, Paul ; Velangi, Mark ; Ware, Russell E. ; Moss, Jon J. ; Lloyd, Adam L. ; Edwards, Sarah ; Mulla, Hussain</creatorcontrib><identifier>ISSN: 2473-9529</identifier><identifier>EISSN: 2473-9537</identifier><identifier>DOI: 10.1182/bloodadvances.2023010099</identifier><identifier>PMID: 37171600</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Research Letter</subject><ispartof>Blood advances, 2023-08, Vol.7 (16), p.4319-4322</ispartof><rights>2023 The American Society of Hematology</rights><rights>2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2023 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-5c87ab238b69a7868555f234af7ff426c7374116e811a6fbcdbd6dadfa539bd43</citedby><cites>FETCH-LOGICAL-c480t-5c87ab238b69a7868555f234af7ff426c7374116e811a6fbcdbd6dadfa539bd43</cites><orcidid>0000-0003-3171-691X ; 0000-0001-9582-0594 ; 0000-0003-2643-765X ; 0000-0003-3862-3230</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424132/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2473952923002513$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,3536,27901,27902,45756,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37171600$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rankine-Mullings, Angela</creatorcontrib><creatorcontrib>Keenan, Russell</creatorcontrib><creatorcontrib>Chakravorty, Subarna</creatorcontrib><creatorcontrib>Inusa, Baba</creatorcontrib><creatorcontrib>Telfer, Paul</creatorcontrib><creatorcontrib>Velangi, Mark</creatorcontrib><creatorcontrib>Ware, Russell E.</creatorcontrib><creatorcontrib>Moss, Jon J.</creatorcontrib><creatorcontrib>Lloyd, Adam L.</creatorcontrib><creatorcontrib>Edwards, Sarah</creatorcontrib><creatorcontrib>Mulla, Hussain</creatorcontrib><title>Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia</title><title>Blood advances</title><addtitle>Blood Adv</addtitle><subject>Research Letter</subject><issn>2473-9529</issn><issn>2473-9537</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkU1v1DAQhi0EolXpX6h85LAp_kji5ISgagtSJS5wtib2mJgm8dZOtuTf49W2Cz1xmpHmnWc-XkIoZ5ecN-JDN4Rgwe5gMpguBROSccba9hU5FaWSRVtJ9fqYi_aEnKf0izHGVS2rVrwlJ1JxxWvGTsly7Zw3YNYNTeBwzhEmS7c9xBFMuPcTzt4kGhwFOuHjhkYEuxZzKJaEGzr4h8Vb2q82ht_rkovUT9T0frARJ_ro554mb-4HpAaHIcNx9PCOvHEwJDx_imfkx83196svxd23269Xn-4KUzZsLirTKOiEbLq6BdXUTVVVTsgSnHKuFLVRUpWc19hwDrXrjO1snV_joJJtZ0t5Rj4euNulG9EanOYIg95GP0JcdQCvX1Ym3-ufYac5K0XJpciE90-EGB4WTLMefdpfkg8JS9Ki4bKqKyH20uYgNTGkFNEd53Cm987pF87pv87l1ot_9zw2PvuUBZ8PAszf2nmMOhmPGWN9RDNrG_z_p_wBW2ux8w</recordid><startdate>20230822</startdate><enddate>20230822</enddate><creator>Rankine-Mullings, Angela</creator><creator>Keenan, Russell</creator><creator>Chakravorty, Subarna</creator><creator>Inusa, Baba</creator><creator>Telfer, Paul</creator><creator>Velangi, Mark</creator><creator>Ware, Russell E.</creator><creator>Moss, Jon J.</creator><creator>Lloyd, Adam L.</creator><creator>Edwards, Sarah</creator><creator>Mulla, Hussain</creator><general>Elsevier Inc</general><general>The American Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3171-691X</orcidid><orcidid>https://orcid.org/0000-0001-9582-0594</orcidid><orcidid>https://orcid.org/0000-0003-2643-765X</orcidid><orcidid>https://orcid.org/0000-0003-3862-3230</orcidid></search><sort><creationdate>20230822</creationdate><title>Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia</title><author>Rankine-Mullings, Angela ; Keenan, Russell ; Chakravorty, Subarna ; Inusa, Baba ; Telfer, Paul ; Velangi, Mark ; Ware, Russell E. ; Moss, Jon J. ; Lloyd, Adam L. ; Edwards, Sarah ; Mulla, Hussain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-5c87ab238b69a7868555f234af7ff426c7374116e811a6fbcdbd6dadfa539bd43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Research Letter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rankine-Mullings, Angela</creatorcontrib><creatorcontrib>Keenan, Russell</creatorcontrib><creatorcontrib>Chakravorty, Subarna</creatorcontrib><creatorcontrib>Inusa, Baba</creatorcontrib><creatorcontrib>Telfer, Paul</creatorcontrib><creatorcontrib>Velangi, Mark</creatorcontrib><creatorcontrib>Ware, Russell E.</creatorcontrib><creatorcontrib>Moss, Jon J.</creatorcontrib><creatorcontrib>Lloyd, Adam L.</creatorcontrib><creatorcontrib>Edwards, Sarah</creatorcontrib><creatorcontrib>Mulla, Hussain</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rankine-Mullings, Angela</au><au>Keenan, Russell</au><au>Chakravorty, Subarna</au><au>Inusa, Baba</au><au>Telfer, Paul</au><au>Velangi, Mark</au><au>Ware, Russell E.</au><au>Moss, Jon J.</au><au>Lloyd, Adam L.</au><au>Edwards, Sarah</au><au>Mulla, Hussain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia</atitle><jtitle>Blood advances</jtitle><addtitle>Blood Adv</addtitle><date>2023-08-22</date><risdate>2023</risdate><volume>7</volume><issue>16</issue><spage>4319</spage><epage>4322</epage><pages>4319-4322</pages><issn>2473-9529</issn><eissn>2473-9537</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37171600</pmid><doi>10.1182/bloodadvances.2023010099</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-3171-691X</orcidid><orcidid>https://orcid.org/0000-0001-9582-0594</orcidid><orcidid>https://orcid.org/0000-0003-2643-765X</orcidid><orcidid>https://orcid.org/0000-0003-3862-3230</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2473-9529
ispartof Blood advances, 2023-08, Vol.7 (16), p.4319-4322
issn 2473-9529
2473-9537
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10424132
source PubMed Central (Open access); ScienceDirect (Online service)
subjects Research Letter
title Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T12%3A46%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy,%20safety,%20and%20pharmacokinetics%20of%20a%20new,%20ready-to-use,%20liquid%20hydroxyurea%20in%20children%20with%20sickle%20cell%20anemia&rft.jtitle=Blood%20advances&rft.au=Rankine-Mullings,%20Angela&rft.date=2023-08-22&rft.volume=7&rft.issue=16&rft.spage=4319&rft.epage=4322&rft.pages=4319-4322&rft.issn=2473-9529&rft.eissn=2473-9537&rft_id=info:doi/10.1182/bloodadvances.2023010099&rft_dat=%3Cproquest_pubme%3E2813565222%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c480t-5c87ab238b69a7868555f234af7ff426c7374116e811a6fbcdbd6dadfa539bd43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2813565222&rft_id=info:pmid/37171600&rfr_iscdi=true